Glioblastoma and Individualized Therapies
This study is exploring new treatment ideas for a very aggressive type of brain cancer called glioblastoma, which hasn't seen much improvement in conventional treatments recently. Even after surgery, radiotherapy, and chemotherapy, this cancer often returns quickly, and the outlook isn't good. Researchers are testing a different approach: creating special, personalised vaccines for each patient. These vaccines are made to match the unique features of an individual's cancer. The hope is that these custom-made vaccines will help the body's immune system fight the cancer more effectively, potentially improving patients' chances and reducing the risk of the cancer coming back. This study is open to adults of all ages.
At a glance
What is this study about?
This study is focused on a very serious type of brain cancer called glioblastoma, which doctors sometimes call WHO grade 4 malignant glioma. For a long time, the main treatments – surgery, radiation, and chemotherapy – haven't changed much, and sadly, this cancer often comes back quickly. This means patients often face a difficult future.
Because standard treatments haven't made big breakthroughs, researchers are looking for new and more personal ways to fight this cancer. In this study, they are investigating whether personalised vaccines can make a difference. These aren't like flu vaccines; instead, they are designed specifically for each patient based on the unique characteristics of their own tumour. The idea is to teach the body's immune system to recognise and attack the cancer cells more effectively.
The main goal of this research is to see if these individualised vaccines, combined with existing treatments, can help prevent the cancer from returning and ultimately improve how long patients live and their quality of life. By understanding each person's cancer at a deeper level, the hope is to create a more targeted and effective treatment strategy.
Key takeaways
- This study explores a new, individualised vaccine for glioblastoma.
- It aims to improve treatment outcomes for a serious brain cancer.
- The vaccine is designed specifically for each patient's tumour.
- It's an addition to standard treatments, not a replacement.
- Open to adults of all ages with a specific type of glioblastoma.
Who may be eligible?
To be considered for this study, you would need to have a specific type of brain cancer called malignant glioma, which has certain genetic features (doctors call this 'IDH WT'). This means the researchers are looking for people with a particular kind of glioblastoma.
There are no age limits for this study; it is open to both men and women of all adult ages. Currently, there are no specific reasons listed that would prevent someone from joining, which sometimes happen in other studies if a person has certain health conditions or is taking particular medications.
Your specialist doctor would be able to check your medical records and test results to confirm if your specific cancer type matches what the researchers are looking for. They can then tell you if you might be suitable for this trial.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Do I have a type of brain cancer called malignant glioma?
- Has my doctor confirmed my cancer has specific genetic features (IDH WT)?
- Am I over 18 (as this is typically for adults, though 'any to any' age is stated)?
- Am I able to attend regular hospital appointments?
What does participation involve?
The detailed plan for what taking part involves isn't fully described here. However, based on similar studies, you could expect to have regular visits to the hospital or clinic. These visits would likely include various checks on your health, such as physical exams, blood tests, and possibly scans to monitor your cancer and how you're responding to treatment.
If you join, you would receive the personalised vaccine as part of the study. The method and frequency of vaccine administration (e.g., injections, how often) would be explained by the study team. You would also continue to receive any standard care or treatments your doctor recommends.
There would also be regular follow-up appointments to track your progress and any side effects. The total duration of your participation would depend on the study's design and how you respond to treatment, but this kind of trial often involves several months or even years of monitoring.
Potential risks and benefits
Locations (1)
- Zentrum für Humangenetik TübingenVerified postcodeTübingen, Germany· Available
Common questions
What is glioblastoma?
Glioblastoma is a very serious and aggressive type of brain cancer that develops from star-shaped brain cells called astrocytes. It often grows quickly.
What is a personalised vaccine?
Unlike standard vaccines that protect against infections, a personalised cancer vaccine is custom-made for one person. It uses information from your own tumour to train your body's immune system to recognise and attack your specific cancer cells.
How is this different from standard treatment?
Standard treatment usually involves surgery, radiation, and chemotherapy. This study adds a personalised vaccine, hoping it will boost your body's own defences against the cancer alongside these existing therapies.
Will I still get my usual treatment?
Yes, you would typically continue to receive standard treatments for glioblastoma as recommended by your doctors, and the personalised vaccine would be given in addition to these.
Who can join this study?
People with a specific type of glioblastoma (malignant glioma, IDH WT) are being sought for this study. There are no age or gender restrictions, but your doctor will need to confirm if your cancer type is suitable.
How to find out more
Saskia Biskup, Dr. Dr.
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.